Intranasal Peptides Explained: Brain Repair, Mitochondria, Stress & Recovery

What if the future of peptide therapy isn't just about which peptide you use — but where you deliver it?

In this episode of The Energy Code, Dr. Mike Belkowski explores one of the most intriguing frontiers in peptide research: intranasal delivery and its potential to create a more brain-oriented route for peptides that influence neurological function, tissue repair, stress regulation, and mitochondrial biology.

The episode begins with the science of nose-to-brain delivery, including the olfactory and trigeminal pathways, systemic absorption through the nasal mucosa, and the possibility of partially circumventing one of neuroscience's biggest obstacles: the blood-brain barrier. But Mike also explains why “intranasal” alone tells us very little about pharmacology — formulation, stability, deposition, device design, concentration, and nasal anatomy can all dramatically affect what actually happens.

Then he breaks down four intriguing formulations: BPC-157, oxytocin, MOTS-c, and MOTS-c + SS-31.

BPC-157 is explored as the repair and regeneration hypothesis, with preclinical research involving traumatic brain injury, ischemia, spinal cord injury, vascular signaling, inflammation, and tissue repair. Oxytocin represents the neuromodulation hypothesis and has by far the strongest direct human intranasal evidence of the four.

MOTS-c takes the conversation directly into mitochondrial medicine. As a mitochondrial-derived signaling peptide, it may help cells recognize and adapt to metabolic stress — and emerging animal research raises fascinating questions about its potential neurological applications. Finally, Mike explores what may be the most intriguing mechanistic pairing: MOTS-c + SS-31, combining cellular metabolic adaptation with direct mitochondrial membrane and cardiolipin support.

The key question isn't simply “What does this peptide do?”

It's: Can we get the peptide to the place where we need it for it to be most effective?

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“The biggest question in peptide medicine... is not simply, what does this peptide do? Rather, can we get this peptide to the place where we need it for it to be most effective?”